Global Micro Electrode Array Market Growth (Status and Outlook) 2023-2029
Microelectrode arrays (MEAs) are devices that contain multiple (tens to thousands) microelectrodes through which neural signals are obtained or delivered, essentially serving as neural interfaces that connect neurons to electronic circuitry. There are two general classes of MEAs: implantable MEAs, used in vivo, and non-implantable MEAs, used in vitro.
LPI (LP Information)' newest research report, the “Micro Electrode Array Industry Forecast” looks at past sales and reviews total world Micro Electrode Array sales in 2022, providing a comprehensive analysis by region and market sector of projected Micro Electrode Array sales for 2023 through 2029. With Micro Electrode Array sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Micro Electrode Array industry.
This Insight Report provides a comprehensive analysis of the global Micro Electrode Array landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Micro Electrode Array portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Micro Electrode Array market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Micro Electrode Array and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Micro Electrode Array.
The global Micro Electrode Array market size is projected to grow from US$ 15 million in 2022 to US$ 34 million in 2029; it is expected to grow at a CAGR of 12.7% from 2023 to 2029.
Micro Electrode Array can be divided into three types: Classical MEA, Multiwell-MEA and CMOS-MEA. Among them, Multiwell-MEA occupies the main share, and revenue in 2019 accounted for 49.65% of the market. Classical MEA and CMOS-MEA accounted for 25.41% and 24.94%, respectively.
The consumption of Micro Electrode Array is mainly concentrated in North America and Europe, and the two regions are accounting for 32.72% and 37.95% of total market in 2019, respectively.
This report presents a comprehensive overview, market shares, and growth opportunities of Micro Electrode Array market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Classical MEA
Multiwell-MEA
CMOS-MEA
Segmentation by application
Cardiomyocytes
Nerve
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
MaxWell Biosystems
Axion Biosystems
3Brain
Multi Channel Systems MCS GmbH
Med64 (former AlphaMED)
Please note: The report will take approximately 2 business days to prepare and deliver.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook